undamentalytics Newsletter

Bausch & Lomb Corp cash flow statement

In fiscal 2025, Bausch & Lomb Corp's operations generated $283m of cash; it spent $349m on capital projects, leaving free cash flow of −$66.0m.

Cash flow statement

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Bausch & Lomb Corp: cash flow statement, annual
Fiscal year2020Dec 20202021Dec 20212022Dec 20222023Dec 20232024Dec 20242025Dec 2025LTMSept 2026
Cash from operations522873345−17232283554
Depreciation and amortisation442415379382436421404
Stock-based pay5062627492149173
Capital spending253193175181291349302
Free cash flow269680170−198−59−66252
Free cash flow after stock pay219618108−272−151−21579

Free cash flow is cash from operations minus capital spending. Free cash flow after stock pay also subtracts stock-based compensation, a real cost to shareholders that the cash flow statement adds back. Dividends, buybacks and shares issued are cash amounts for the period.

Compare with peers

Head to head: BLCO vs RMDBLCO vs DXCMBLCO vs STEBLCO vs IDXX

More: Health Care Equipment stocks compared, Health Care sector, rankings of US companies

Figures from Bausch & Lomb Corp's SEC filings (10-K and 10-Q), retrieved October 31, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Bausch & Lomb Corp.